Cargando…
Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017
PURPOSE: Today, the decision to treat patients with chemotherapy for early breast cancer (EBC) is made based on the patient’s individual risk stratification and tumor biology. In cases with chemotherapy indication, the neoadjuvant application (NACT) is the preferred option in comparison with primary...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191903/ https://www.ncbi.nlm.nih.gov/pubmed/36604331 http://dx.doi.org/10.1007/s00404-022-06902-9 |